Related Experiment Video
Updated: Jan 30, 2026
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid
Zongming Liu1,2,3,4, Yanzhi Wang1,2, Sheheryar Kabraji1,5
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Abstract:
Breast cancer brain metastasis (BCBM) remains a major clinical problem. Approximately 10-16% of patients with breast cancer develop brain metastases (BCBM). However, no systemic therapy has gained regulatory approval for the specific treatment of BCBM and this remains an area of persistent, unmet medical need. Rapid, predictive and clinically-relevant animal models are critical to study the biology of brain metastases and to identify effective therapeutic approaches for patients with BCBM. Here, we describe a method for efficient establishment of orthotopic mouse models of patient-derived brain metastases via an improved intracarotid injection protocol that permits tumor cell growth in the unique brain microenvironment without compromising the blood-brain barrier (BBB). We demonstrate that our newly improved models of patient-derived brain metastases recapitulate the histologic, molecular, and genetic characteristics of their matched patient tumor specimens and thus represent a potentially powerful tool for pre-clinical and translational research.
Insights
Developing new mouse models for breast cancer brain metastasis (BCBM) is crucial. This study presents an improved method for creating predictive BCBM models, aiding the search for effective treatments.
Area of Science:
- Oncology
- Neuroscience
- Translational Medicine
Background:
- Breast cancer brain metastasis (BCBM) affects 10-16% of patients.
- No approved systemic therapies specifically target BCBM, highlighting an unmet clinical need.
- Development of predictive, clinically-relevant animal models is essential for BCBM research.
Purpose of the Study:
- To establish efficient, orthotopic mouse models of patient-derived brain metastases.
- To utilize an improved intracarotid injection protocol for tumor cell engraftment.
- To create models that accurately reflect the unique brain microenvironment and blood-brain barrier integrity.
Main Methods:
- Developed an improved intracarotid injection technique for establishing orthotopic brain metastasis models.
- Utilized patient-derived tumor cells for xenografting in mice.
- Validated model fidelity through histological, molecular, and genetic analysis.
Main Results:
- Successfully established orthotopic mouse models of patient-derived brain metastases.
- The improved protocol allows tumor cell growth within the brain microenvironment without compromising the blood-brain barrier.
- The developed models accurately recapitulate the characteristics of the original patient tumors.
Conclusions:
- The improved intracarotid injection method efficiently generates predictive models of breast cancer brain metastasis.
- These patient-derived models are valuable tools for pre-clinical research and therapeutic development for BCBM.
- This approach addresses the critical need for better animal models in understanding and treating BCBM.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
00:57Modified Boxplots
However, the box plot does not tell the reader about outliers - values that lie far from the center of the data. We can modify the standard box and whisker plot to identify the outliers and visualize the actual spread of the data in a sample.
Initially, we calculate the adjusted...
02:07Improving Translational Accuracy
02:07Improving Translational Accuracy
01:15Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
03:02Measurement: Derived Units